These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11361222)

  • 1. Inflammatory arthropathy in MRL hematopoietic chimeras undergoing Fas mediated graft-versus-host syndrome.
    Bonardelle D; Bobé P; Reynès M; Amouroux J; Tricottet V; Godeau F; Kiger N
    J Rheumatol; 2001 May; 28(5):956-61. PubMed ID: 11361222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
    Bobé P; Bonardelle D; Reynès M; Godeau F; Mahiou J; Joulin V; Kiger N
    J Immunol; 1997 Nov; 159(9):4197-204. PubMed ID: 9379013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
    Bonardelle D; Benihoud K; Kiger N; Bobé P
    J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
    Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
    Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
    J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.
    Hsu HC; Zhang HG; Song GG; Xie J; Liu D; Yang PA; Fleck M; Wintersberger W; Zhou T; Edwards CK; Mountz JD
    Arthritis Rheum; 2001 Sep; 44(9):2146-59. PubMed ID: 11592380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.
    Hadj-Slimane R; Chelbi-Alix MK; Tovey MG; Bobé P
    J Interferon Cytokine Res; 2004 Dec; 24(12):717-28. PubMed ID: 15684739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selected elimination of mouse alloreactive T cells by Fas-FasL passway].
    Liu L; Zou P; Xu Z; Hu Z; Chen Y; Song S
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):187-90. PubMed ID: 12133454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
    Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the mechanism of graft-vs-host like disease in [lpr/lpr----+/+] chimera].
    Matsunaga T
    Hokkaido Igaku Zasshi; 1987 Sep; 62(5):779-89. PubMed ID: 2961673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.
    Lombard C; McKallip RJ; Hylemon PB; Nagarkatti PS; Nagarkatti M
    Clin Immunol; 2003 Nov; 109(2):144-53. PubMed ID: 14597213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-mediated cholangiopathy in the murine model of graft versus host disease.
    Ueno Y; Ishii M; Yahagi K; Mano Y; Kisara N; Nakamura N; Shimosegawa T; Toyota T; Nagata S
    Hepatology; 2000 Apr; 31(4):966-74. PubMed ID: 10733554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor.
    Connolly K; Cho YH; Duan R; Fikes J; Gregorio T; LaFleur DW; Okoye Z; Salcedo TW; Santiago G; Ullrich S; Wei P; Windle K; Wong E; Yao XT; Zhang YQ; Zheng G; Moore PA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):25-33. PubMed ID: 11408521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transfers in X-irradiated mice congenic at the lpr locus: some paradoxical effects.
    Mosbach-Ozmen L; Loor F
    Thymus; 1987; 9(4):197-210. PubMed ID: 3313828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis.
    Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Shirwan H; Yaniv I; Askenasy N
    Exp Hematol; 2007 Oct; 35(10):1601-12. PubMed ID: 17889725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers.
    Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S
    Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel recombinant congenic mouse strain developing arthritis with enthesopathy.
    Mori S; Tanda N; Ito MR; Oishi H; Tsubaki T; Komori H; Zhang MC; Ono M; Nishimura M; Nose M
    Pathol Int; 2008 Jul; 58(7):407-14. PubMed ID: 18577108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.